欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0940/002
药品名称Quatriga Low Osmo Peripheral
活性成分
    • Alanine 3.5 g/l
    • Arginine 3.0 g/l
    • Calcium chloride 0.14 g/l
    • fish oil, rich in omega 3-acids 5.3 g/l
    • Glucose 68.0 g/l
    • Glycine 2.8 g/l
    • Histidine 0.75 g/l
    • Isoleucine 1.3 g/l
    • Leucine 1.9 g/l
    • Lysine acetate 1.7 g/l
    • Magnesium sulfate 0.3 g/l
    • medium-chain triglycerides 11.0 g/l
    • Methionine 1.1 g/l
    • OLIVE OIL 8.8 g/l
    • Phenylalanine 1.3 g/l
    • Potassium chloride 1.1 g/l
    • Proline 2.8 g/l
    • Serine 1.6 g/l
    • Sodium acetate 0.85 g/l
    • SODIUM GLYCEROPHOSPHATE 1.0 g/l
    • SOYBEAN OIL 11.0 g/l
    • Taurine 0.25 g/l
    • Threonine 1.1 g/l
    • Tryptophan 0.5 g/l
    • Tyrosine 0.1 g/l
    • Valine 1.6 g/l
    • Zinc sulfate 3.2 mg/l
剂型Emulsion for infusion
上市许可持有人Fresenius Kabi AB, Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Italy (IT)
许可日期2021/02/16
最近更新日期2025/02/07
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase